CoChat

Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer

Mendiratta, Prateek, Mostaghel, Elahe, Guinney, Justin, Tewari, Alok K., Porrello, Alessandro, Barry, William T., Nelson, Peter S., Febbo, Phillip G. · 2009 · Journal of Clinical Oncology
Cited by 126

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Purpose: Despite treatments which lower circulating androgens, advanced prostate cancers often maintain androgen receptor (AR) signaling. The variable response to secondary hormonal manipulations in men with castrate-resistant prostate cancer (CRPC) creates a compelling need for strategies to individualize therapy based on the molecular features of each patient's tumor. Methods: A transcription-based AR activity signature was developed from an androgen-sensitive prostate cancer cell (LNCaP) and tested on independent data sets of prostate cancer cell lines and human tumors to assess its precision and accuracy in detecting AR activity. The AR signature was applied to multiple sets of prostate specimens to determine how AR activity changes with hormone therapy and progression and oncogenic pathway analysis was used to identify biologic pathways correlating with AR activity. Results: A robust AR signature accurately predicts AR activity in multiple prostate cancer cell lines, has minimal variation between replicate samples, and accurately reflects an individual's hormone status and intraprostatic dihydrotestosterone levels. The AR signature finds AR activity to be high in local, untreated prostate tumors and decreased in prostate tissue after neoadjuvant hormone therapy and in CRPC. Heterogeneity of AR activity exists along the spectrum of prostate cancer progression and decreasing predicted AR activity correlates with increasing predicted Src activity and sensitivity to dasatinib (Src-targeting kinase inhibitor). Conclusion: A transcription-based AR signature can detect AR activity within individual prostate cancer specimens and has the potential to help individualize and improve care for patients with CRPC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2008.17.2882

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 31

  1. 10.1007/s10552-007-9083-8 · DOI · Paper page
  2. 10.1158/0008-5472.CAN-04-2938 · DOI · Paper page
  3. 10.1073/pnas.191235898 · DOI · Paper page
  4. 10.1016/S0022-5347(05)66935-2 · DOI · Paper page
  5. 10.1158/1078-0432.CCR-06-2344 · DOI · Paper page
  6. Amler LC, 2000, Cancer Res, 60, 6134
  7. 10.1016/j.ccr.2006.09.005 · DOI · Paper page
  8. 10.1038/nature04296 · DOI · Paper page
  9. 10.1038/ng1167 · DOI · Paper page
  10. 10.1073/pnas.201162998 · DOI · Paper page
  11. 10.1093/bioinformatics/19.2.185 · DOI · Paper page
  12. 10.1093/nar/gng015 · DOI · Paper page
  13. 10.1073/pnas.1530509100 · DOI · Paper page
  14. 10.1158/1078-0432.CCR-05-1652 · DOI
  15. 10.1038/nature04296 · DOI · Paper page
  16. 10.1038/nm1491 · DOI · Paper page
  17. 10.1172/JCI20032 · DOI · Paper page
  18. 10.1158/1078-0432.CCR-05-0585 · DOI · Paper page
  19. 10.1073/pnas.182376299 · DOI · Paper page
  20. 10.1186/gb-2002-3-7-research0032 · DOI · Paper page
  21. 10.1210/me.2005-0309 · DOI · Paper page
  22. 10.1186/gb-2007-8-11-r255 · DOI · Paper page
  23. 10.1186/1471-2407-7-64 · DOI · Paper page
  24. 10.1016/j.ccr.2005.10.001 · DOI · Paper page
  25. 10.1038/ng1935 · DOI · Paper page
  26. Edwards J, 2003, Clin Cancer Res, 9, 5271
  27. 10.1038/sj.onc.1207344 · DOI · Paper page
  28. 10.1172/JCI21739 · DOI
  29. de la Taille A, 2003, Clin Cancer Res, 9, 1801
  30. 10.1200/JCO.2007.15.1951 · DOI
  31. 10.1038/nm1107-1276b · DOI

Cited by

See all 126

Metadata

Authors
Mendiratta, P., Mostaghel, E., Guinney, J., Tewari, A. K., Porrello, A., Barry, W. T., Nelson, P. S., & Febbo, P. G.
Venue
Journal of Clinical Oncology
Published
2009-04-20
Volume
27
Issue
12
Pages
2022-2029
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2144509773
Cited by
126
References
9
FWCI
14.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer. https://app.cochat.ai/papers/10.1200/jco.2008.17.2882
The paper
Mendiratta, P., Mostaghel, E., Guinney, J., Tewari, A. K., Porrello, A., Barry, W. T., Nelson, P. S., & Febbo, P. G. (2009). Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.17.2882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.